Recent News

• 02.09.2026 - Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026
• 01.05.2026 - Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference
• 12.01.2025 - Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference
• 11.25.2025 - Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access
• 11.11.2025 - Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries
• 10.30.2025 - Integra LifeSciences Reports Third Quarter 2025 Financial Results
• 10.15.2025 - Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025
• 10.08.2025 - Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting
• 09.22.2025 - Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer
• 09.22.2025 - Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer

Recent Filings

• 02.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2026 - 3 Initial statement of beneficial ownership of securities
• 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 12.12.2025 - 8-K Current report
• 11.06.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.30.2025 - EX-99.1 EX-99.1
• 10.30.2025 - 8-K Current report
• 10.30.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.14.2025 - 4 Statement of changes in beneficial ownership of securities